HOSTESS BRANDS, LLC ISSUES RECALL ON POSSIBLE UNDECLARED
HOSTESS BRANDS, LLC ISSUES RECALL ON POSSIBLE UNDECLARED PEANUT RESIDUE IN CERTAIN SNACK CAKE AND DONUT PRODUCTS
Move Comes as Part of FDA’s Safety Advisory Regarding Grain Craft Flour Recall
June 3, 2016 -- Hostess Brands, LLC is voluntarily recalling 710,000 cases of select snack cakes and donuts as a direct result of the recent recall by our supplier, Grain Craft, of certain lots of its flour for undeclared peanut residue. The Hostess Brands products subject to the recall were produced using the Grain Craft flour that has now been recalled and, as a result, these products may contain low levels of undeclared peanut residue. More information about the Grain Craft recall can be found on the FDA’s website at: www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm504002.htm.
While those who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume products containing peanut allergens, the amount of peanut exposure from use of the flours and affected products is considered to be low and not expected to cause adverse health effects in the vast majority of peanut allergic consumers. To date, Hostess has received notice of two allergic reactions related to the product covered by this recall. Out of an abundance of caution, we are recalling the specific products listed on the attachment.
This recall applies only to the products listed in the attachment. This recall does not affect any other Hostess Brands products. The Hostess Brands products affected by the recall include single serve (snack cakes and donuts), multipack boxes and bagged donuts. The products were sold to mass merchandisers, grocery stores, distributors, dollar stores, drug stores, and convenience stores throughout the United States and Mexico. Anyone who has purchased an affected product and who has a sensitivity or allergy to peanuts is encouraged to discard it or return it to the place of purchase for a full refund.
Consumers with questions may contact 1-800-686-2813 Monday through Friday from 8:30 am to 4:30 pm Central time. Consumers may also visit www.hostesscakes.com.
For a complete list of recalled products please click here.
To leave us your information for product replacement coupons, please visit www.hostessinfo.com
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Top 5 Most Recently Viewed Articles
NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...
Continue Reading
Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...
Continue Reading
Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...
Continue Reading
MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...
Continue Reading
Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...
Continue Reading
